As of 2026-04-05, the EV/EBITDA ratio of Bionik Laboratories Corp (BNKL) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BNKL's latest enterprise value is 1.73 mil USD. BNKL's TTM EBITDA according to its financial statements is -4.78 mil USD. Dividing these 2 quantities gives us the above BNKL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 2.9x | 0.1x |
| Forward P/E multiples | 0.1x - 2.9x | 0.1x |
| Fair Price | (0.00) - (0.01) | (0.00) |
| Upside | -169203.8% - -1255955.5% | -176857.0% |
| Date | EV/EBITDA |